Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer

Thumbnail
Fulltext:
234186.pdf
Size:
656.8Kb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2021
Author(s)
Vrede, S.W.
Weelden, W.J. van
Visser, N.C.M.
Bulten, J.
Putten, L.J.M. van der
Vijver, Koen van de
Reijnen, C.
Pijnenborg, J.M.A.
Source
Gynecologic Oncology, 161, 3, (2021), pp. 787-794
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/234186   https://hdl.handle.net/2066/234186
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.